Overall rank by patents
#20,906
of 50,000 tracked assignees
USPTO PatentsView assignee record - 13 granted patents across 3 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION).
The verdict
According to USPTO PatentsView, Cequence ranks #20,906 of 50,000 tracked US assignees by granted-patent volume, with 13 patents across 3 technology areas.
USPTO PatentsView assignee plate
Corpus R20906 · US Corporation #20,906 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Cassina S.p.a. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Renco World · near
31 score
Cequence Security · this assignee
31 score
Doosan Machine Tools · near
31 score
Shanghai Pharmaceuti… · near
31 score
D3D · near
31 score
3D Lighting Innovati… · lowest
7 score
What this shows Cequence's Innovation Score is 31.0/100 (top 64% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Cequence Security, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2018. By volume, Cequence sits between Cassina S.p.a. and CHI MEI Medical Center.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CASSINA S.P.A.
13 patents
CELL BIOTECH CO., LTD.
13 patents
CENTER FOR ADVANCED SOFT ELECTRONICS
13 patents
CENTIPEDE SEMI LTD.
13 patents
CERAMICHE ATLAS CONCORDE S.p.A.
13 patents
CERN—EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH
13 patents
CESIUM GS, INC.
13 patents
CHI MEI MEDICAL CENTER
13 patents
CEQUENCE SECURITY, INC.
13 patents
What this shows Cequence holds 13 patents at rank #20,895, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #20,895 in granted patent volume.
Other assignees with the most granted patents in Cequence's primary technology class.
Two PlainPatent-derived peer sets for Cequence, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (31 here).
Cequence's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 Top 64% higher than 36% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 7.7% |
| 2019 | 2 | 15.4% |
| 2020 | 3 | 23.1% |
| 2021 | 2 | 15.4% |
| 2022 | 3 | 23.1% |
| 2024 | 1 | 7.7% |
| 2025partial year | 1 | 7.7% |
Top 3 of 3 technology areas
Overall rank by patents
#20,906
of 50,000 tracked assignees
31.0 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.